Profile

Arbor Life Labs’ commercial-stage regenerative technology treats a range of dermatology disorders. Arbor’s lead platform ALRV5XR sets a new standard of care in efficacy and safety for the treatment of alopecia in women and men. The clinical development pipeline in psoriasis and atopic dermatitis is advanced. ALRV5XR is a multi-targeting technology that activates stem cells and regulates disease and tissue-specific molecular targets. The addressable market exceeds $50 billion with rapid time to commercialization.

Arbor Life Labs logo

Website

arborlifelabs.com

Contact


Event details

Date: June 5 - 8, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

33 in total